Is a Hemoglobin Level of 5.8 Normal?

A hemoglobin level of 5.8 g/dL is not normal. It is dangerously low and qualifies as severe, life-threatening anemia. For reference, healthy hemoglobin typically falls between about 12 and 16 g/dL in adult women and about 13.5 and 17.5 g/dL in adult men, so 5.8 represents roughly half or less of what your body needs to deliver oxygen efficiently. If you or someone you know has a hemoglobin reading this low, it warrants urgent medical attention.

How Far Below Normal Is 5.8?

To understand how serious 5.8 g/dL is, it helps to know the thresholds doctors use. The World Health Organization defines anemia as hemoglobin below 12 g/dL in non-pregnant women and below 13 g/dL in men. Severe anemia is generally classified as hemoglobin below 7 g/dL. A reading of 5.8 falls well below even that severe cutoff. In hospitalized patients, international guidelines recommend considering a blood transfusion when hemoglobin drops below 7 g/dL, and many clinicians regard anything below 6 g/dL as an emergency requiring immediate intervention.¹

In children, the picture varies with age. Reference ranges in kids shift as they grow: hemoglobin climbs from roughly 10 g/dL in infants a few months old toward adult-like values of 13 g/dL and above by adolescence.² Even using the lowest normal boundary for young infants, 5.8 g/dL is still severely below range at any pediatric age.

What 5.8 g/dL Feels Like

At a hemoglobin this low, your blood is carrying barely enough oxygen to keep vital organs functioning. Most people with hemoglobin near 5.8 feel profoundly unwell. Symptoms can range from extreme fatigue, dizziness, and cold skin to heart palpitations, shortness of breath at rest, and confusion. In more severe presentations, the heart compensates by pumping harder and faster, which can lead to heart failure or fluid buildup in the lungs.³

That said, how bad you feel depends partly on how quickly the hemoglobin dropped. If anemia develops slowly over weeks or months, the body adapts to some degree: the heart increases its output, blood vessels dilate, and cells become more efficient at extracting oxygen. This is why some people with chronic conditions walk into a clinic with hemoglobin in the 5-to-6 range and appear surprisingly functional, while someone who loses blood rapidly to that same level can go into shock. Research on acute anemia confirms that very low hemoglobin levels can be survived short-term without lasting damage, but that chronic anemia at even mild-to-moderate levels is linked to poorer long-term health outcomes.⁴ In other words, feeling “okay” at 5.8 does not mean your body is fine with it.

Risks to the Heart and Other Organs

The heart is particularly vulnerable when hemoglobin drops this low. In people with existing heart disease, even mild anemia raises the likelihood of complications. A large study of patients with acute coronary syndromes found that cardiovascular death risk increased in a graded fashion as hemoglobin fell, with each 1 g/dL drop below about 11 g/dL carrying meaningfully worse odds.⁵ At 5.8 g/dL, that gradient becomes very steep. Even in people without known heart problems, the sustained strain of pumping harder to compensate for low oxygen delivery can damage the heart muscle over time.

Beyond the heart, severe anemia affects cognition and mood. Depression and significant impairment of thinking ability have been documented in people with very low hemoglobin.³ Organs like the kidneys and brain, which are highly dependent on steady oxygen supply, are among the first to show dysfunction when hemoglobin sinks to these levels.

Common Causes of Hemoglobin This Low

Hemoglobin rarely drops to 5.8 g/dL from a single minor cause. Something significant is usually going on, and the underlying reason matters enormously for treatment. The most common categories include:

Iron deficiency from blood loss: Chronic bleeding is the single most frequent driver of severe anemia, particularly from the gastrointestinal tract. In men and postmenopausal women, iron-deficiency anemia often originates from lesions in the stomach, small intestine, or colon, and roughly six in ten patients with GI bleeding are found to have iron-deficiency anemia.⁶ In premenopausal women, heavy menstrual periods are another common source. Endoscopy studies show that a bleeding source in the upper or lower GI tract can be identified in the majority of patients with unexplained iron deficiency.⁷
Nutritional deficiency: Severe lack of vitamin B12 or folate impairs the bone marrow’s ability to produce healthy red blood cells. B12 deficiency disrupts the normal development of red cell precursors and causes them to die prematurely.⁸ In some patients, both B12 and iron are depleted at the same time, compounding the problem.⁹
Chronic kidney disease: The kidneys produce a hormone called erythropoietin that tells the bone marrow to make red blood cells. When kidney function declines, erythropoietin levels fall and red cell production drops.
Blood cancers and bone marrow failure: Leukemia, aplastic anemia, myelodysplastic syndromes, and other marrow disorders can directly suppress red cell production, sometimes driving hemoglobin to dangerously low levels.
Hemolysis: Conditions that destroy red blood cells faster than the body can replace them, including autoimmune disorders, sickle cell disease, and enzyme deficiencies like G6PD deficiency, can cause rapid drops in hemoglobin.

Figuring out the cause typically involves blood tests beyond just the hemoglobin number: iron studies, vitamin levels, a reticulocyte count to see how hard the marrow is working, and sometimes imaging or endoscopy to find a bleeding source.

How Hemoglobin This Low Gets Treated

When hemoglobin is at 5.8 g/dL, treatment usually has two phases: stabilize first, then fix the underlying cause.

For stabilization, blood transfusion is the fastest way to raise hemoglobin. International guidelines from the AABB, based on dozens of randomized trials involving more than 20,000 adults, recommend considering transfusion when hemoglobin falls below 7 g/dL in most hospitalized patients. In patients with heart disease or those undergoing certain surgeries, clinicians may use a slightly higher trigger of 7.5 to 8 g/dL.¹ At 5.8, you are well below any of these thresholds, and transfusion is almost always warranted unless the patient’s specific situation prevents it. A Cochrane review of transfusion strategies confirmed that restricting transfusion to lower thresholds (around 7 g/dL) is generally as safe as transfusing more liberally, but that finding applies to patients already near the threshold, not to those significantly below it.¹⁰

Once hemoglobin is stabilized, treatment shifts to addressing whatever caused the drop. Iron-deficiency anemia from GI bleeding, for example, requires finding and treating the bleeding lesion as well as replenishing iron stores, often initially through intravenous iron because oral iron is absorbed too slowly when the deficit is this large. In patients with chronic kidney disease, intravenous iron supplementation has been shown to improve anemia in about two-thirds of cases without the need for erythropoietin injections or transfusions.¹¹ For B12-deficient patients, injections of vitamin B12 along with iron supplementation can gradually restore normal blood counts.⁹

The Pregnancy Dimension

Hemoglobin of 5.8 during pregnancy is especially alarming. Normal pregnancy involves a physiological drop in hemoglobin because blood volume expands faster than red cell production, but levels below about 11 g/dL are considered anemic in pregnant women, and anything below 7 g/dL is classified as severe. Research links hemoglobin below 6 g/dL in pregnancy to poor outcomes for both mother and baby, including premature delivery, low birth weight, restricted fetal growth, and increased risk of bleeding complications.¹²

A large population-based study found that even moderate anemia in pregnancy more than doubled the risk of preterm birth and dramatically increased the likelihood of needing a blood transfusion during or after delivery. Severe anemia amplified those risks further and was tied to higher rates of neonatal death and low Apgar scores at birth.¹³ In most settings, pregnant women with hemoglobin near 5.8 g/dL are transfused promptly while the cause is investigated, because the stakes for the baby’s development are time-sensitive.

Severe Anemia in Children

Children can reach hemoglobin levels this low for somewhat different reasons than adults. Iron deficiency remains the single most common cause of severe anemia across all pediatric age groups, accounting for roughly 38% of cases in one cohort study. In younger children, autoimmune hemolysis and G6PD enzyme deficiency make up a larger share than in older kids.¹⁴ In infants and toddlers, the most typical culprits behind iron-deficiency anemia are rapid growth outpacing iron intake, low birth weight, and excessive consumption of cow’s milk, which is low in iron and can irritate the gut lining enough to cause small amounts of blood loss.¹⁵

The 2023 AABB guidelines recommend a transfusion threshold of 7 g/dL for most critically ill children who are hemodynamically stable. Children with congenital heart disease may need a higher threshold depending on their specific cardiac condition and surgical status.¹ At 5.8, a child would almost certainly receive a transfusion in any clinical setting, though the underlying cause still needs to be identified and treated to prevent recurrence.

When Transfusion Is Not an Option

Some patients decline blood transfusions for religious or personal reasons, and a small but growing field of “bloodless medicine” has developed strategies for managing severe anemia without transfusion. These protocols typically involve aggressive supplementation: high-dose intravenous erythropoietin to stimulate the bone marrow, intravenous iron, vitamin C to enhance iron absorption, folate, and B12. One published protocol for patients who refuse transfusion recommends erythropoietin at 40,000 units intravenously daily until hemoglobin rises above 7 g/dL, along with daily intravenous iron for ten days before switching to oral supplementation.¹⁶

These approaches can work, but they are slower than transfusion and carry more uncertainty. The body needs time to produce new red blood cells even with maximal pharmacological stimulation, and at 5.8 g/dL the margin for any further decline is perilously thin. Bloodless medicine works best when the care team can minimize additional blood loss through careful surgical technique, reduced blood draws, and sometimes oxygen-rich environments. It remains a specialized area of practice, and outcomes depend heavily on having experienced clinicians and the right resources.

Transfusion Is Not Risk-Free Either

While blood transfusion is lifesaving at hemoglobin levels this low, it comes with its own set of risks that increase with each unit transfused. The two most serious acute complications are transfusion-related acute lung injury, in which the immune system reacts to donor blood components and causes fluid to flood the lungs, and transfusion-associated circulatory overload, where the added volume overwhelms the heart. Together, these are the leading causes of transfusion-related serious harm and death.¹⁷ Allergic reactions, fever, and the small risk of infection transmission round out the list. These risks are part of why modern guidelines favor restrictive transfusion strategies whenever safely possible, though at 5.8 g/dL the benefit of transfusion clearly outweighs the risk.

Could 5.8 Refer to Something Else?

There is one common source of confusion worth addressing. If you received a result of 5.8 from a blood test labeled “HbA1c” or “A1c,” that is a completely different measurement. HbA1c reflects your average blood sugar over the past two to three months, expressed as a percentage. A reading of 5.8% would place you in the prediabetic range (5.7% to 6.4%), but it has nothing to do with how much hemoglobin is in your blood or whether you are anemic. The two tests share the word “hemoglobin” because A1c measures the fraction of hemoglobin molecules that have glucose attached to them, but their clinical meanings are unrelated.

If your lab report says “Hgb” or “Hemoglobin” with a result of 5.8 and the units are g/dL, that is the anemia-related measurement discussed throughout this article. If it says “HbA1c” or “A1c” and the result is 5.8%, you are looking at a diabetes screening test. The distinction matters: one is a medical emergency, and the other is a signal to discuss blood sugar management with your doctor. Checking the label and units on your lab report will tell you which one you are dealing with.

Why Some People Walk Around with Very Low Hemoglobin

It surprises many people that hemoglobin can drop this low without someone collapsing. The explanation lies in how gradually the anemia developed. When blood loss or red cell underproduction happens slowly, the cardiovascular system compensates day by day. The heart rate creeps up, blood vessels relax to reduce resistance, and tissues extract a higher fraction of the oxygen delivered to them. These adaptations are remarkably effective at maintaining organ function in the short term, which is why clinicians occasionally encounter patients in outpatient clinics with hemoglobin in the 4-to-6 range who are walking and talking.

The problem is that compensated does not mean healthy. The heart is working overtime, and that extra load wears on it. Cognitive function quietly deteriorates. Exercise tolerance shrinks to nearly nothing. Wound healing slows. Infection risk rises because the immune system becomes less effective. And any sudden additional stress, like a new infection, a minor surgical procedure, or a small amount of further bleeding, can tip a compensated patient into crisis. The fact that someone “feels okay” at 5.8 g/dL is a testament to the body’s adaptability, but it is not a reason to delay treatment.

1
JAMA. Red Blood Cell Transfusion: 2023 AABB International Guidelines
2
PubMed Central. Paediatric Reference Intervals and Curves for Haemoglobin Estimated Using Direct Methods: A Systematic Review and Meta‐Analysis
3
PubMed. Symptomatology of anemia
4
PubMed Central. The Limits of Acute Anemia
5
PubMed. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes
6
PubMed Central. Diagnosis and treatment of iron-deficiency anemia in gastrointestinal bleeding: A systematic review
7
PubMed. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia
8
PubMed Central. Cobalamin deficiency can mask depleted body iron reserves
9
PubMed Central. A case of anemia caused by combined vitamin B12 and iron deficiency manifesting as short stature and delayed puberty
10
PubMed Central. Transfusion thresholds and other strategies for guiding red blood cell transfusion
11
PubMed. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis
12
PubMed Central. Complications of anemia in pregnancy: An updated overview for healthcare professionals
13
PubMed Central. Maternal and Perinatal Morbidity and Mortality Associated With Anemia in Pregnancy
14
Blood. Iron Deficiency Anemia As a Leading Cause of Severe Anemia in Children May be Associated with Unnecessary Red Blood Cells (RBCs) Transfusion
15
PubMed Central. Iron deficiency anemia from diagnosis to treatment in children
16
American Journal of Case Reports. Successfully Managing Severe Anemia in a Trauma Patient Who Refused Blood Transfusion: A Case Report
17
PubMed Central. TACO and TRALI: biology, risk factors, and prevention strategies